Correlation Between Bellicum Pharmaceuticals and Cellectis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bellicum Pharmaceuticals and Cellectis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bellicum Pharmaceuticals and Cellectis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bellicum Pharmaceuticals and Cellectis SA, you can compare the effects of market volatilities on Bellicum Pharmaceuticals and Cellectis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bellicum Pharmaceuticals with a short position of Cellectis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bellicum Pharmaceuticals and Cellectis.

Diversification Opportunities for Bellicum Pharmaceuticals and Cellectis

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bellicum and Cellectis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bellicum Pharmaceuticals and Cellectis SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectis SA and Bellicum Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bellicum Pharmaceuticals are associated (or correlated) with Cellectis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectis SA has no effect on the direction of Bellicum Pharmaceuticals i.e., Bellicum Pharmaceuticals and Cellectis go up and down completely randomly.

Pair Corralation between Bellicum Pharmaceuticals and Cellectis

If you would invest (100.00) in Bellicum Pharmaceuticals on December 21, 2024 and sell it today you would earn a total of  100.00  from holding Bellicum Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Bellicum Pharmaceuticals  vs.  Cellectis SA

 Performance 
       Timeline  
Bellicum Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bellicum Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Bellicum Pharmaceuticals is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
Cellectis SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cellectis SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Bellicum Pharmaceuticals and Cellectis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bellicum Pharmaceuticals and Cellectis

The main advantage of trading using opposite Bellicum Pharmaceuticals and Cellectis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bellicum Pharmaceuticals position performs unexpectedly, Cellectis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectis will offset losses from the drop in Cellectis' long position.
The idea behind Bellicum Pharmaceuticals and Cellectis SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stocks Directory
Find actively traded stocks across global markets